Etude Resume (Retraitement Sunitinib Rein Metastatique)
Phase of Trial: Phase IV
Latest Information Update: 15 May 2016
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Acronyms ETUDE RESUME
- Sponsors Pfizer
- 15 May 2016 Results (n=52) published in the European Journal of Cancer
- 15 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2014 Planned End Date changed from 1 Dec 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.